Proper Counseling and Dispensing of Isotretinoin Capsule Products by Community Pharmacists in UAE: A Simulated Patient Study

References

• Tan JK, Vasey K, Fung KY. Beliefs and perceptions of patients with acne. J Am Acad Dermatol. 2001;44(3):439–445. doi:10.1067/mjd.2001.11134011209112
   PubMed Web of Science ®Google Scholar
• Dréno B, Layton A, Zouboulis CC, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol. 2013;27(9):1063–1070. doi:10.1111/jdv.1206123302006
   PubMed Web of Science ®Google Scholar
• The quality of life in acne: a comparison with general medical conditions using generic questionnaires. - PubMed - NCBI. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10233319. Accessed 925, 2019.
   Google Scholar
• Impact of acne on quality of life of students at Sultan Qaboos University. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371463/. Accessed 925, 2019
   Google Scholar
• Babies, blemishes and FDA: a history of accutane regulation in the United States. Available from: https://dash.harvard.edu/handle/1/8963867. Accessed 925, 2019.
   Google Scholar
• Crijns I, Zomerdijk I, Sturkenboom M, de Jong-van den Berg L, Straus S. A comparison of pregnancy prevention programmes in Europe. Expert Opin Drug Saf. 2014;13(4):411–420. doi:10.1517/14740338.2014.88767824506812
   PubMed Web of Science ®Google Scholar
• Lelubre M, Hamdani J, Senterre C, et al. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: survey among French-speaking health care professionals and patients in Belgium. Pharmacoepidemiol Drug Saf. 2018;27(6):668–673. doi:10.1002/pds.444129726056
   PubMed Web of Science ®Google Scholar
• iPLEDGE. SAFETY NOTICE; 2016 Available from: https://www.ipledgeprogram.com/iPledgeUI/home.u. Accessed 113, 2019.
   Google Scholar
• Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543.2316538
   PubMedGoogle Scholar
• Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series, No. 961; 2011 Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js18676en/. Accessed 928, 2019.
   Google Scholar
• AlGhamdi KM, Khurram H, Asiri YA, Mandil A. Dermatologists’ level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential. Int J Dermatol. 2011;50(9):1094–1098. doi:10.1111/j.1365-4632.2011.04875.x22126870
   PubMed Web of Science ®Google Scholar
• Kerr KW, Wosinska ME. Patient access in restrictive risk management programs: the case of iPLEDGE. Ther Innov Regul Sci. 2017;51(1):16–23. doi:10.1177/216847901666326630235995
   PubMed Web of Science ®Google Scholar
• Pinheiro SP, Kang EM, Kim CY, Governale LA, Zhou EH, Hammad TA. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States. Pharmacoepidemiol Drug Saf. 2013;22(12):1251–1257. doi:10.1002/pds.348123913625
   PubMed Web of Science ®Google Scholar
• Tkachenko E, Singer S, Sharma P, Barbieri J, Mostaghimi A. US food and drug administration reports of pregnancy and pregnancy-related adverse events associated with isotretinoin. JAMA Dermatol. 2019;155(10):1175. doi:10.1001/jamadermatol.2019.1388
   PubMed Web of Science ®Google Scholar
• Tan J, Boyal S, Desai K, Knezevic S. Oral isotretinoin: new developments relevant to clinical practice. Dermatol Clin. 2016;34(2):175–184. doi:10.1016/j.det.2015.11.00227015777
   PubMed Web of Science ®Google Scholar
• FIP. Community pharmacy section; 2013 Available from: https://www.fip.org/community-pharmacy. Accessed 98, 2019.
   Google Scholar
• Rashid ZA, Al-Tabakha MM, Alomar MJ. Community pharmacist’s’ knowledge and practice toward oral isotretinoin prescription: a systemic review. J Pharm Sci. 75(2–3):56–60. doi:10.1691/ph.2020.9891
   Web of Science ®Google Scholar
• Biset N, Lelubre M, Senterre C, et al. Assessment of medication adherence and responsible use of isotretinoin and contraception through Belgian community pharmacies by using pharmacy refill data. Patient Prefer Adherence. 2018;12:153. doi:10.2147/PPA.S14935529403267
   PubMed Web of Science ®Google Scholar
• Controlled Medication Resource Center » in Health. Available from: https://www.inhealth.ae/controlled-medication/. Accessed 928, 2019.
   Google Scholar
• Boucher N, Beaulac-Baillargeon L. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations. Can Fam Physician Med. 2006;52:338–339.
   Google Scholar
• Isotretinoin and pregnancy. Medscape. Available from: http://www.medscape.com/viewarticle/492119. Accessed 102, 2019.
   Google Scholar
• Isotretinoin: medlinePlus drug information. Available from: https://medlineplus.gov/druginfo/meds/a681043.html. Accessed 102, 2019.
   Google Scholar
• UAE has over 2000 private pharmacies, 4000 professionals. Available from: http://wam.ae/en/details/1395228626943. Accessed 105, 2019.
   Google Scholar
• Mobark DM, Al-Tabakha MM, Hasan S. Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study. Pharm Pract. 2019;17(2):1465. doi:10.18549/PharmPract.2019.2.1465
   Web of Science ®Google Scholar
• BAD. British association of dermatologists - Patient Information Leaflets (PILs). Available from: http://www.bad.org.uk/for-the-public/patient-information-leaflets/isotretinoin/?showmore=1&returnlink=http%3A%2F%2Fwww.bad.org.uk%2Ffor-the-public%2Fpatient-information-leaflets#.XYKDaygzbIU. Accessed 918, 2019.
   Google Scholar
• iPledge REMS - Public home page. Available from: https://www.ipledgeprogram.com/iPledgeUI/home.u. Accessed 1010, 2019.
   Google Scholar
• British Association of Dermatologists - Patient Information Leaflets (PILs). Available from: http://www.bad.org.uk/for-the-public/patient-information-leaflets/isotretinoin/?showmore=1&returnlink=http%3A%2F%2Fwww.bad.org.uk%2Ffor-the-public%2Fpatient-information-leaflets#.XYKDaygzbIU. Accessed 918, 2019.
   Google Scholar
• Siminoff LA, Rogers HL, Waller AC, et al. The advantages and challenges of unannounced standardized patients methodology to assess healthcare communication. Patient Educ Couns. 2011;82(3):318–324. doi:10.1016/j.pec.2011.01.02121316182
   PubMed Web of Science ®Google Scholar
• Alrwisan AA, Alshammari TM, Tahir KW, Aleissa FM, Aljadhey HS. Community pharmacists’ knowledge of isotretinoin safety. Saudi Med J. 2014;35(1):81–84.24445895
   PubMed Web of Science ®Google Scholar
• Tuha A, Gurbie Y, Hailu HG. Evaluation of knowledge and practice of pharmacy professionals regarding the risk of medication use during pregnancy in Dessie Town, Northeast Ethiopia: a cross-sectional study. J Pregnancy. 2019;2019:1–8. doi:10.1155/2019/2186841
   Web of Science ®Google Scholar
• Altman EM. Isotretinoin and pregnancy prevention: do we need to take a long, hard look at ourselves? JAMA Dermatol. 2014;150(4):361–362. doi:10.1001/jamadermatol.2013.697324258339
   PubMed Web of Science ®Google Scholar
• Dabaghzadeh F, Hajjari R. Practice of community pharmacists related to multivitamin supplements: a simulated patient study in Iran. Int J Clin Pharm. 2018;40(1):190–195. doi:10.1007/s11096-017-0579-329270735
   PubMed Web of Science ®Google Scholar
• Marfo AF, Owusu-Daaku FT, Kyerewaa-Akromah E. Patient knowledge of medicines dispensed from Ghanaian community pharmacies. Pharm Pract. 2013;11(2):66. doi:10.4321/S1886-36552013000200002
   PubMedGoogle Scholar
• Kos M, Horvat N. Contribution of Slovenian community pharmacist counseling to patients’ knowledge about their prescription medicines: a cross-sectional study. Croat Med J. 2015;1(56):41–49.
   Google Scholar
• Ceulemans M, Liekens S, Van Calsteren K, Allegaert K, Foulon V. Community pharmacists’ attitudes, barriers, knowledge and counseling practice with regard to preconception, pregnancy and lactation. Res Social Adm Pharm. 2019. doi:10.1016/j.sapharm.2019.12.010
   Web of Science ®Google Scholar
• Hamoudi N, Shirwaikar A, Ali H, Al Ayoubi E. Pharmaceutical consultation in UAE community pharmacies. Indian J Pharm Sci. 2011;73(4):404–408. doi:10.4103/0250-474X.9562122707824
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh M, Yousefi N, Sharifinia H. Chain drugstores: opportunities and threats. Iran J Pharm Res. 2014;13(3):739–741.25276175
   PubMed Web of Science ®Google Scholar
• Specialty pharmacy - ASHP. Available from: https://www.ashp.org:443/PharmacyPractice/Resource Centers/Specialty Pharmacy. Accessed 14, 2020.
   Google Scholar
• Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123–133. doi:10.2165/0002512-200926020-0000419220069
   PubMed Web of Science ®Google Scholar
• Leguelinel-Blache G, Dubois F, Bouvet S, et al. Improving patient’s primary medication adherence. Medicine (Baltimore). 2015;94(41):41. doi:10.1097/MD.0000000000001805
   Web of Science ®Google Scholar
• Boskovic J, Mestrovic A, Leppee M, Bago M, Sostar Z, Naletilic D. Pharmacist competences and impact of pharmacist intervention on medication adherence: an observational study. Psychiatr Danub. 2016;28(4):420–427.27855435
   PubMed Web of Science ®Google Scholar
• Zomerdijk IM, Ruiter R, Houweling LM, et al. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands. BMJ Open. 2014;4(11):e005602. doi:10.1136/bmjopen-2014-005602
   Web of Science ®Google Scholar
• Crijns H, Straus S, Gispen‐de Wied C, de Jong-van den Berg L. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review. Br J Dermatol. 2011;164(2):238–244. doi:10.1111/j.1365-2133.2010.09976.x20716214
   PubMed Web of Science ®Google Scholar
• Teichert M, Visser LE, Dufour M, et al. Isotretinoin use and compliance with the Dutch pregnancy prevention programme. Drug Saf. 2010;33(4):315–326. doi:10.2165/11319190-000000000-0000020297863
   PubMed Web of Science ®Google Scholar
• Babar Z-U-D, Scahill S. Barriers to effective pharmacy practice in low- and middle-income countries. Integr Pharm Res Pract. 2014;25. doi:10.2147/IPRP.S35379
   Google Scholar
• Raguideau F, Mezzarobba M, Zureik M, Weill A, Ricordeau P, Alla F. Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin. Pharmacoepidemiol Drug Saf. 2015;24(5):526–533. doi:10.1002/pds.376325753265
   PubMed Web of Science ®Google Scholar
• Mitchell AA, Van Bennekom CM, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med. 1995;333(2):101–106. doi:10.1056/NEJM1995071333302067777014
   PubMed Web of Science ®Google Scholar
• Cyrulnik AA, Viola KV, Gewirtzman AJ, Cohen SR. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life. Int J Dermatol. 2012;51(9):1123–1130. doi:10.1111/j.1365-4632.2011.05409.x22909370
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Krakowski AC. A novel patient support program to address isotretinoin adherence: proof-of-concept analysis. J Drugs Dermatol. 2015;14(4):375–379.25844611
   PubMed Web of Science ®Google Scholar
• Baker DW, Hasnain-Wynia R, Kandula NR, Thompson JA, Brown ER. Attitudes toward health care providers, collecting information about patients’ race, ethnicity, and language. Med Care. 2007;45(11):1034–1042. doi:10.1097/MLR.0b013e318127148f18049343
   PubMed Web of Science ®Google Scholar
• Tully MP, Beckman-Gyllenstrand A, Bernsten CB. Factors predicting poor counselling about prescription medicines in Swedish community pharmacies. Patient Educ Couns. 2011;83(1):3–6. doi:10.1016/j.pec.2010.04.02920605395
   PubMed Web of Science ®Google Scholar
• Schommer JC, Wiederholt JB. Pharmacists’ perceptions of patients’ needs for counseling. Am J Hosp Pharm. 1994;51(4):478–485. doi:10.1093/ajhp/51.4.4788017412
   PubMedGoogle Scholar
• McIntosh J, Rafie S, Wasik M, et al. Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the women’s health practice and research network of the American College of clinical pharmacy. Pharmacotherapy. 2011;31(4):424–437. doi:10.1592/phco.31.4.42421449630
   PubMed Web of Science ®Google Scholar
• Rouse MJ. Continuing professional development in pharmacy - Michael J Rouse; 2004 Available from: https://journals.sagepub.com/doi/abs/10.1177/875512250402000509. Accessed 129, 2019.
   Google Scholar
• Adepu R, Shariff A. Development, validation and implementation of continuous professional development programmes for community pharmacists. Indian J Pharm Sci. 2010;72(5):557–563. doi:10.4103/0250-474X.7852021694985
   PubMed Web of Science ®Google Scholar
• Kansanaho H, Pietilä K, Airaksinen MA.Can a long‐term continuing education course in patient counselling promote a change in the practice of Finnish community pharmacists? Int J Pharm Pract. 2003;11(3):153–160. Doi:10.1211/0022357021945
   Google Scholar
• Watson MC, Norris P, Granas AG. A systematic review of the use of simulated patients and pharmacy practice research. Int J Pharm Pract. 2006;14(2):83–93. doi:10.1211/ijpp.14.2.0002
   Google Scholar